Emergent
ProMetic to acquire Winnipeg plasma collection centre
Adds to vertical integration of the manufacturing platform.
Emergent BioSolutions acquiring biopharmaceutical Cangene for $222M
Deal complements Emergent’s development of vaccines and therapeutics.
